Literature DB >> 20137629

[Relationship between polymorphism sites of IRF5, TLR-9 and SLE patients in Shandong Han population].

Wei-qing Song1, Hua-hui Li, Hua-bo Chen, Jiang-shui Yuan, Xiao-jie Yin.   

Abstract

OBJECTIVE: To investigate two single nucleotide polymorphism sites of IRF5 and TLR-9 and to detect their relationship with SLE (systemic lupus erythematosus) in a Han population from Shandong province.
METHODS: The polymorphisms of rs2004640 G/T, rs10954213 G/A in IRF-5 and rs187084C/T, rs352139A/G in TLR-9 were detected with PCR-RFLP in 92 cases of SLE and 88 healthy controls. The genotype and allele frequencies were calculated and analyzed.
RESULTS: (1) The genotype frequencies of GG, GT and TT in rs2004640 site in SLE were 0.198, 0.521 and 0.281 respectively. The difference was significant between SLE and controls (chi(2) = 8.73, P < 0.05); the genotype frequencies of GG, GA and AA at rs109542130 site in SLE were 0.318, 0.409 and 0.273 respectively. The difference was significant between SLE and controls (chi(2) = 6.36, P < 0.05). (2) The genotype frequencies of CC, CT and TT at rs187084 site in SLE were 0.185, 0.413 and 0.402 respectively. There was no difference between SLE and controls (chi(2) = 2.99, P > 0.05); the genotype frequencies of AA, AG and GG at rs352139 site in SLE were 0.228, 0.533 and 0.239 respectively. There was no difference between SLE and controls (chi(2) = 4.54, P > 0.05).
CONCLUSION: The polymorphism of rs2004640 and rs10954213 in IRF5 may be associated with SLE in the population of Han nationality from Shandong province. However, the polymorphism of rs187084 and rs352139 in TLR-9 is not associated with SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20137629

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  8 in total

1.  Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.

Authors:  Liang Tang; Pengcheng Wan; Yong Wang; Jiabao Pan; Yan Wang; Bifeng Chen
Journal:  Inflamm Res       Date:  2015-08-21       Impact factor: 4.575

2.  Interferon regulatory factor (IRF)-5: a potential therapeutic target for ankylosing spondylitis.

Authors:  Wang-Dong Xu; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2011-09-18       Impact factor: 2.631

3.  Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: a meta-analysis.

Authors:  Hui-Feng Liu; Xiang-Jie An; Yan Yang; Liu Yang; Yan Li; Chang-Zheng Huang; Juan Tao; Ya-Ting Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

Review 4.  TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.

Authors:  Duan Wang; Chao Zhang; Zongke Zhou; Fuxing Pei
Journal:  Rheumatol Int       Date:  2015-12-07       Impact factor: 2.631

5.  The association between bile salt export pump single-nucleotide polymorphisms and primary biliary cirrhosis susceptibility and ursodeoxycholic acid response.

Authors:  Rui-rui Chen; Yuan-jun Li; Xin-min Zhou; Lu Wang; Juan Xing; Shuang Han; Li-na Cui; Lin-hua Zheng; Kai-chun Wu; Yong-quan Shi; Zhe-yi Han; Ying Han; Dai-ming Fan
Journal:  Dis Markers       Date:  2014-10-19       Impact factor: 3.434

6.  Association between TLR-9 gene rs187084 polymorphism and knee osteoarthritis in a Chinese population.

Authors:  Mingfeng Zheng; Shiyuan Shi; Qi Zheng; Yifan Wang; Xiaozhang Ying; Yanghui Jin
Journal:  Biosci Rep       Date:  2017-10-17       Impact factor: 3.840

7.  Role of toll-interacting protein gene polymorphisms in leprosy Mexican patients.

Authors:  Margarita Montoya-Buelna; Mary Fafutis-Morris; Alvaro J Tovar-Cuevas; Anabell Alvarado-Navarro; Yeminia Valle; Jorge R Padilla-Gutierrez; Jose F Muñoz-Valle; Luis E Figuera-Villanueva
Journal:  Biomed Res Int       Date:  2013-11-04       Impact factor: 3.411

8.  The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India.

Authors:  Panneer Devaraju; Sonal Mehra; Reena Gulati; Paul T Antony; Vikramraj K Jain; Durga Prasanna Misra; Vir Singh Negi
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.